Prospera Financial Services’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-200
Closed -$3K 1346
2022
Q2
$3K Sell
200
-4,011
-95% -$60.2K ﹤0.01% 1519
2022
Q1
$59K Buy
+4,211
New +$59K ﹤0.01% 1298